Saikosaponin A and D Inhibit Adipogenesis via the AMPK and MAPK Signaling Pathways in 3T3-L1 Adipocytes

Obesity is a lipid metabolism disorder caused by genetic, medicinal, nutritional, and other environmental factors. It is characterized by a complex condition of excess lipid accumulation in adipocytes. Adipogenesis is a differentiation process that converts preadipocytes into mature adipocytes and c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sung Ho Lim, Ho Seon Lee, Hyo-Kyung Han, Chang-Ik Choi
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/5749a8606d284ac3b6082736b90fb409
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5749a8606d284ac3b6082736b90fb409
record_format dspace
spelling oai:doaj.org-article:5749a8606d284ac3b6082736b90fb4092021-11-11T16:52:59ZSaikosaponin A and D Inhibit Adipogenesis via the AMPK and MAPK Signaling Pathways in 3T3-L1 Adipocytes10.3390/ijms2221114091422-00671661-6596https://doaj.org/article/5749a8606d284ac3b6082736b90fb4092021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11409https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Obesity is a lipid metabolism disorder caused by genetic, medicinal, nutritional, and other environmental factors. It is characterized by a complex condition of excess lipid accumulation in adipocytes. Adipogenesis is a differentiation process that converts preadipocytes into mature adipocytes and contributes to excessive fat deposition. Saikosaponin A (SSA) and saikosaponin D (SSD) are triterpenoid saponins separated from the root of the Bupleurum chinensis, which has long been used to treat inflammation, fever, and liver diseases. However, the effects of these constituents on lipid accumulation and obesity are poorly understood. We investigated the anti-obesity effects of SSA and SSD in mouse 3T3-L1 adipocytes. The MTT assay was performed to measure cell viability, and Oil Red O staining was conducted to determine lipid accumulation. Various adipogenic transcription factors were evaluated at the protein and mRNA levels by Western blot assay and quantitative reverse transcription polymerase chain reaction (qRT-PCR). Here, we showed that SSA and SSD significantly inhibited lipid accumulation without affecting cell viability within the range of the tested concentrations (0.938–15 µM). SSA and SSD also dose-dependently suppressed the expression of peroxisome proliferator-activated receptor gamma (PPARγ), CCAAT/enhancer binding protein alpha (C/EBPα), sterol regulatory element binding protein-1c (SREBP-1c), and adiponectin. Furthermore, the decrease of these transcriptional factors resulted in the repressed expression of several lipogenic genes including fatty acid binding protein (FABP4), fatty acid synthase (FAS), and lipoprotein lipase (LPL). In addition, SSA and SSD enhanced the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) and its substrate, acetyl-CoA carboxylase (ACC), and inhibited the phosphorylation of extracellular-regulated kinase 1/2 (ERK1/2) and p38, but not c-Jun-N-terminal kinase (JNK). These results suggest that SSA and SSD inhibit adipogenesis through the AMPK or mitogen-activated protein kinase (MAPK) pathways in the early stages of adipocyte differentiation. This is the first study on the anti-adipogenic effects of SSA and SSD, and further research in animals and humans is necessary to confirm the potential of saikosaponins as therapeutic agents for obesity.Sung Ho LimHo Seon LeeHyo-Kyung HanChang-Ik ChoiMDPI AGarticlesaikosaponin3T3-L1 cellsadipogenesisAMPK pathwayMAPK pathwayBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11409, p 11409 (2021)
institution DOAJ
collection DOAJ
language EN
topic saikosaponin
3T3-L1 cells
adipogenesis
AMPK pathway
MAPK pathway
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle saikosaponin
3T3-L1 cells
adipogenesis
AMPK pathway
MAPK pathway
Biology (General)
QH301-705.5
Chemistry
QD1-999
Sung Ho Lim
Ho Seon Lee
Hyo-Kyung Han
Chang-Ik Choi
Saikosaponin A and D Inhibit Adipogenesis via the AMPK and MAPK Signaling Pathways in 3T3-L1 Adipocytes
description Obesity is a lipid metabolism disorder caused by genetic, medicinal, nutritional, and other environmental factors. It is characterized by a complex condition of excess lipid accumulation in adipocytes. Adipogenesis is a differentiation process that converts preadipocytes into mature adipocytes and contributes to excessive fat deposition. Saikosaponin A (SSA) and saikosaponin D (SSD) are triterpenoid saponins separated from the root of the Bupleurum chinensis, which has long been used to treat inflammation, fever, and liver diseases. However, the effects of these constituents on lipid accumulation and obesity are poorly understood. We investigated the anti-obesity effects of SSA and SSD in mouse 3T3-L1 adipocytes. The MTT assay was performed to measure cell viability, and Oil Red O staining was conducted to determine lipid accumulation. Various adipogenic transcription factors were evaluated at the protein and mRNA levels by Western blot assay and quantitative reverse transcription polymerase chain reaction (qRT-PCR). Here, we showed that SSA and SSD significantly inhibited lipid accumulation without affecting cell viability within the range of the tested concentrations (0.938–15 µM). SSA and SSD also dose-dependently suppressed the expression of peroxisome proliferator-activated receptor gamma (PPARγ), CCAAT/enhancer binding protein alpha (C/EBPα), sterol regulatory element binding protein-1c (SREBP-1c), and adiponectin. Furthermore, the decrease of these transcriptional factors resulted in the repressed expression of several lipogenic genes including fatty acid binding protein (FABP4), fatty acid synthase (FAS), and lipoprotein lipase (LPL). In addition, SSA and SSD enhanced the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) and its substrate, acetyl-CoA carboxylase (ACC), and inhibited the phosphorylation of extracellular-regulated kinase 1/2 (ERK1/2) and p38, but not c-Jun-N-terminal kinase (JNK). These results suggest that SSA and SSD inhibit adipogenesis through the AMPK or mitogen-activated protein kinase (MAPK) pathways in the early stages of adipocyte differentiation. This is the first study on the anti-adipogenic effects of SSA and SSD, and further research in animals and humans is necessary to confirm the potential of saikosaponins as therapeutic agents for obesity.
format article
author Sung Ho Lim
Ho Seon Lee
Hyo-Kyung Han
Chang-Ik Choi
author_facet Sung Ho Lim
Ho Seon Lee
Hyo-Kyung Han
Chang-Ik Choi
author_sort Sung Ho Lim
title Saikosaponin A and D Inhibit Adipogenesis via the AMPK and MAPK Signaling Pathways in 3T3-L1 Adipocytes
title_short Saikosaponin A and D Inhibit Adipogenesis via the AMPK and MAPK Signaling Pathways in 3T3-L1 Adipocytes
title_full Saikosaponin A and D Inhibit Adipogenesis via the AMPK and MAPK Signaling Pathways in 3T3-L1 Adipocytes
title_fullStr Saikosaponin A and D Inhibit Adipogenesis via the AMPK and MAPK Signaling Pathways in 3T3-L1 Adipocytes
title_full_unstemmed Saikosaponin A and D Inhibit Adipogenesis via the AMPK and MAPK Signaling Pathways in 3T3-L1 Adipocytes
title_sort saikosaponin a and d inhibit adipogenesis via the ampk and mapk signaling pathways in 3t3-l1 adipocytes
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/5749a8606d284ac3b6082736b90fb409
work_keys_str_mv AT sungholim saikosaponinaanddinhibitadipogenesisviatheampkandmapksignalingpathwaysin3t3l1adipocytes
AT hoseonlee saikosaponinaanddinhibitadipogenesisviatheampkandmapksignalingpathwaysin3t3l1adipocytes
AT hyokyunghan saikosaponinaanddinhibitadipogenesisviatheampkandmapksignalingpathwaysin3t3l1adipocytes
AT changikchoi saikosaponinaanddinhibitadipogenesisviatheampkandmapksignalingpathwaysin3t3l1adipocytes
_version_ 1718432238414069760